NCT06894056 is a clinical trial in Basal Cell Cancer, sponsored by Sifa Okulu - Independent Research Center of Dermatology and Venereology.

Who is sponsoring NCT06894056?

NCT06894056 is sponsored by Sifa Okulu - Independent Research Center of Dermatology and Venereology.

What condition does NCT06894056 study?

NCT06894056 studies Basal Cell Cancer, Grafting.

Is NCT06894056 still recruiting?

NCT06894056 is currently completed. Last updated 25 March 2025.

Last reviewed 2025-03-25 · How we verify

NCT06894056

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigating the Effects of Orienting Skin Grafts Parallel to Skin Tension Lines on Quality of Life in Head and Neck Located Basal Cell Carcinoma

Completed Last updated 25 March 2025

What this trial tests

trial in Basal Cell Cancer in 71 participants. Completed in 22 February 2025.

Timeline

20 November 2021

Primary endpoint
22 February 2025

22 February 2025

Quick facts

Lead sponsor	Sifa Okulu - Independent Research Center of Dermatology and Venereology
Status	Completed
Study type	OBSERVATIONAL
Enrollment	71
Start date	20 November 2021
Primary completion	22 February 2025
Estimated completion	22 February 2025
Sites	1 location across Turkey (Türkiye)

Conditions studied

Basal Cell Cancer — all drugs for Basal Cell Cancer →
Grafting — all drugs for Grafting →

Sponsor

Sifa Okulu - Independent Research Center of Dermatology and Venereology

Who can join

Adults 18 to 65, any sex, with Basal Cell Cancer or Grafting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the effect of orienting graft for treatment of skin cancer in patients who undergo skin cancer excision and grafting for their skin cancer. The main question to answer is Does orienting the grafts parallel with skin tension lines have any effect on quality of life or cosmetic results? Participants who already underwent or planned to undergo an excision and grafting procedure will answer a qaulity of life tool and cosmetic results will be evaluated by two seperate dermatologist.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Basal Cell Cancer

Currently open trials in the same condition.

NCT06398418 — R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06894056 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sifa Okulu - Independent Research Center of Dermatology and Venereology
Last refreshed: 25 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06894056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing